Abstract
Aquaporin (AQP) water channel proteins are responsible for osmotically driven water transport across cell membranes of mammalian tissues, lower animals and plants. Recently, the cDNAs encoding ten mammalian AQPs with widely different tissue expression patterns have been cloned. This article reviews the recent progress in molecular cloning, gene organization, chromosomal localization and mutations of human AQPs. Sequence and genomic structure analyses indicate that the AQP gene family contains at least three subgroup. AQPs 0, 1, 2, 4, 5 and 6 have 40-50 percent amino acid homology and their genes contain 4 exons. AQPs 3, 7 and 9 belong to distinct subfamily that contains 6 exons and functions as transporters of small neutral solutes as well as water. AQP8 belongs to the third subgroup with unique exon-intron boundaries. Mutations in AQP2 cause human nephrogenic diabetes insipidus (NDI). The understanding of AQP genetics is important in studying the pathogenesis of diseases related AQP disorders a nd finding new targets for therapy.
Keywords: Aquaporin Gene Family, AQP, Human aquaporins, Human AQP9, Aquaporin Gene Cluster, CDNA sequences
Current Genomics
Title: The Human Aquaporin Gene Family
Volume: 1 Issue: 1
Author(s): Baoxue Yang
Affiliation:
Keywords: Aquaporin Gene Family, AQP, Human aquaporins, Human AQP9, Aquaporin Gene Cluster, CDNA sequences
Abstract: Aquaporin (AQP) water channel proteins are responsible for osmotically driven water transport across cell membranes of mammalian tissues, lower animals and plants. Recently, the cDNAs encoding ten mammalian AQPs with widely different tissue expression patterns have been cloned. This article reviews the recent progress in molecular cloning, gene organization, chromosomal localization and mutations of human AQPs. Sequence and genomic structure analyses indicate that the AQP gene family contains at least three subgroup. AQPs 0, 1, 2, 4, 5 and 6 have 40-50 percent amino acid homology and their genes contain 4 exons. AQPs 3, 7 and 9 belong to distinct subfamily that contains 6 exons and functions as transporters of small neutral solutes as well as water. AQP8 belongs to the third subgroup with unique exon-intron boundaries. Mutations in AQP2 cause human nephrogenic diabetes insipidus (NDI). The understanding of AQP genetics is important in studying the pathogenesis of diseases related AQP disorders a nd finding new targets for therapy.
Export Options
About this article
Cite this article as:
Yang Baoxue, The Human Aquaporin Gene Family, Current Genomics 2000; 1 (1) . https://dx.doi.org/10.2174/1389202003351832
DOI https://dx.doi.org/10.2174/1389202003351832 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
MicroRNAs as Biomarkers for Birth Defects
MicroRNA Machine Intelligence Techniques for the Identification and Diagnosis of COVID-19
Current Medicinal Chemistry Vcsa1 Gene Peptides for the Treatment of Inflammatory and Allergic Reactions
Recent Patents on Inflammation & Allergy Drug Discovery Diabetes Exacerbates Nanoparticles Induced Brain Pathology
CNS & Neurological Disorders - Drug Targets mTOR Inhibitors in Tuberous Sclerosis Complex
Current Neuropharmacology Immunosuppression in Liver Transplantation
Current Drug Targets The Effect of TNFα-Inhibitors on Cardiovascular Events in Patients with Rheumatoid Arthritis: An Updated Systematic Review of the Literature
Current Rheumatology Reviews Is Atherothromboaspiration a Possible Solution for the Prevention of No-Reflow Phenomenon in Acute Coronary Syndromes? Single Centre Experience and Review of the Literature
Current Vascular Pharmacology Novel Anticancer Targets and Drug Discovery in Post Genomic Age
Current Medicinal Chemistry - Anti-Cancer Agents Endothelial Dysfunction in Morbid Obesity
Current Pharmaceutical Design ATP-Sensitive K+ Channels: Current and Putative Target for the Prevention and Treatment of Cardiovascular Diseases
Vascular Disease Prevention (Discontinued) Differential Regulation of microRNAs in Patients with Ischemic Stroke
Current Neurovascular Research The Effects of Lipid-Regulating Therapy on Haemostatic Parameters
Current Pharmaceutical Design Systemic Sclerosis-Associated Interstitial Lung Disease: Lessons from Clinical Trials, Outcome Measures, and Future Study Design
Current Rheumatology Reviews Is There a Genetic Susceptibility to Bronchopulmonary Dysplasia?
Current Respiratory Medicine Reviews CCR5 as a Potential Target in Cancer Therapy: Inhibition or Stimulation?
Anti-Cancer Agents in Medicinal Chemistry Pharmacotherapy of Dilated Cardiomyopathy
Current Pharmaceutical Design Valve Endothelial Cells – Not Just Any Old Endothelial Cells
Current Vascular Pharmacology Why Multiples of 21? Why does Selenoprotein P Contain Multiple Selenocysteine Residues?
Current Nutraceuticals “The Tools of the Trade” – An Overview of the Pharmacology of the Endocannabinoid System
Current Pharmaceutical Design